Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Horizons Psychedelic Stock Index ETF HPSYF

Consumer Cyclical
PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index (the Underlying Index, Bloomberg ticker: HPSYKTR), net of expenses. The ETF will not seek to hedge any foreign currency exposure To achieve the ETFs investment objective, the ETF invests and holds equity securities of the Constituent Issuers in substantially the same proportion as the current Underlying Index. To the extent permitted, the ETF will generally be fully invested in or exposed to the Underlying Index at all times and will have substantial exposure to the North American psychedelics industry.


GREY:HPSYF - Post by User

Horizons Psychedelic Stock Index ETF
<< Previous
 Bullboard Posts
User Avatar Image
(273)
•••
Post by partystockeron Mar 08, 2022 11:24am
58 Views
Post# 34495412

Promising Psilocybin Treatment Study

Promising Psilocybin Treatment Study Promising study supporting the use of psilocybin as a treatment for alcohol and drug dependency. Big implications for funds like $PSYK and Origin Therapeutics.

https://journals.sagepub.com/doi/abs/10.1177/0269881114565144
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities